Shorr, Andrew F.

Epidemiology and Outcomes of Health-care–Associated Pneumonia

Kollef, M. H., Shorr, A., Tabak, Y. P., Gupta, V., Liu, L. Z., & Johannes, R. S. (2005) · Chest

Nosocomial Infections in ICUPneumonia and Respiratory Infections

Cited by 948

Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)

Tabah, A., Bassetti, M., Kollef, M. H., Zahar, J.-R., Paiva, J.-A., Timsit, J.-F., Roberts, J. A., Schouten, J., Giamarellou, H., Rello, J., et al. (2020) · Intensive Care Medicine

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 191

Timing of antibiotic therapy in the ICU

Kollef, M. H., Shorr, A. F., Bassetti, M., Timsit, J.-F., Micek, S. T., Michelson, A. P., & Garnacho-Montero, J. (2021) · Critical Care

Antibiotics Pharmacokinetics and EfficacySepsis Diagnosis and Treatment

Cited by 161

Secular trends in candidemia-related hospitalization in the United States, 2000–2005

Zilberberg, M. D., Shorr, A. F., & Kollef, M. H. (2008) · Infection Control & Hospital Epidemiology

Antifungal resistance and susceptibilityInfection Control in Healthcare

Cited by 137

Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study

Zilberberg, M. D., Kollef, M. H., Arnold, H., Labelle, A., Micek, S. T., Kothari, S., & Shorr, A. F. (2010) · BMC Infectious Diseases

Antifungal resistance and susceptibilityAntibiotic Use and Resistance

Cited by 128

A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia

Shorr, A. F., Myers, D. E., Huang, D. B., Nathanson, B. H., Emons, M. F., & Kollef, M. H. (2013) · BMC Infectious Diseases

Antimicrobial Resistance in StaphylococcusPneumonia and Respiratory Infections

Cited by 84

Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data

Zilberberg, M. D., Shorr, A. F., Huang, H., Chaudhari, P., Paly, V. F., & Menzin, J. (2014) · BMC Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 62

Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. database

Shorr, A. F., Gupta, V., Sun, X., Johannes, R. S., Spalding, J., & Tabak, Y. P. (2009) · Critical Care Medicine

Antifungal resistance and susceptibilityInfective Endocarditis Diagnosis and Management

Cited by 62

Cholestatic jaundice associated with the use of metformin

Desilets, D. J., Shorr, A. F., Moran, K. A., & Holtzmuller, K. C. (2001) · American Journal of Gastroenterology

Drug-Induced Hepatotoxicity and ProtectionLiver Disease Diagnosis and Treatment

Cited by 50

Fungal infections in the ICU

Zilberberg, M. D., & Shorr, A. F. (2009) · Infectious Disease Clinics of North America

Antifungal resistance and susceptibilityNosocomial Infections in ICU

Cited by 42